SECONDARY ACUTE MYELOID LEUKEMIA
Clinical trials for SECONDARY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SECONDARY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for SECONDARY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat leukemia
Disease control OngoingThis early-phase study tests a combination of three drugs (bortezomib, sorafenib, and decitabine) in 15 adults with acute myeloid leukemia (AML), including older patients who cannot have standard treatment or those with relapsed disease. The main goal is to find the safest dose a…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 01:38 UTC
-
Smarter CMV strategy may protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study tested a modified approach to prevent and manage cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV treatment could still keep patients safe while reducing unneces…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 01:37 UTC
-
Could a Pre-Treatment boost Chemo's power against tough leukemia?
Disease control OngoingThis study tests whether adding a drug called decitabine before standard chemotherapy can help more people with acute myeloid leukemia (AML) achieve remission. About 178 adults with AML that is not the most treatable type will receive either a low or high dose of decitabine follo…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC
-
Talking therapy tackles tiredness in blood cancer patients
Symptom relief OngoingThis study looks at whether cognitive behavioral therapy (CBT) can help people with acute myeloid leukemia or lymphoma who feel very tired from their cancer or treatment. About 48 patients will learn new ways to think and act to better cope with fatigue, anxiety, and depression. …
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 29, 2026 01:34 UTC